Pain And Addiction: Mitigating Risk | 18024
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2464

Journal of Addiction Research & Therapy received 2464 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Pain and addiction: Mitigating risk

3rd International Conference and Exhibition on Addiction Research & Therapy

William S Jacobs

Keynote: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.014

C hronic pain has a high prevalence, especially in the United States, and carries significant morbidity and health care costs. The adequate treatment of patients with chronic pain is the responsibility of all health care providers, regardless of specialty. Opioids have long been-and continue to remain-an important piece of that treatment, but their use has increased exponentially over the past 20 years and resulted in near-identical increases in the misuse of, abuse of, and addiction to these drugs. In this presentation, the author will review the history of the paradigm shift in opioid prescribing, the scope and extent of the resulting problems associated with that shift, and the evidence of efficacy and safety when chronic non-cancer pain is treated with prescription opioids. Recommendations are made to assess initial and ongoing risk, and monitor patients (who truly benefit), to help practitioners responsibly continue to prescribe opioids appropriately, while reducing misuse, abuse, and addiction
William S Jacobs, MD, is board certified in Anesthesiology, Pain Medicine, and Addiction Medicine. A Phi Beta Kappa, Magna Cum Laude University of Georgia undergraduate and graduate of the Medical College of Georgia, he did his Anesthesiology Residency at the University of Alabama-Birmingham before matriculating to UF for his Addiction Medicine Fellowship. He is currently Associate Professor in Psychiatry and Addiction Medicine: Co-Chief of Pain Medicine at the University of Florida. His work has included serving as Medical Director of multiple addiction treatment programs as well as expert witness work, consulting with state and federal agencies, authoring peer reviewed works and as on pharmacologic studies